Source:http://linkedlifedata.com/resource/pubmed/id/21285385
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2011-3-1
|
| pubmed:abstractText |
Rapid advances in diabetes genetic epidemiology may lead to a new era of "personalized medicine" based on individual genetic risk assessment. There is minimal experience to guide how best to clinically implement such testing so that results (e.g., "higher" or "lower" relative genetic risk) improve rather than reduce patient motivation for behavior change.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
1935-5548
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
34
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
568-73
|
| pubmed:dateRevised |
2011-9-15
|
| pubmed:meshHeading | |
| pubmed:year |
2011
|
| pubmed:articleTitle |
Perceived impact of diabetes genetic risk testing among patients at high phenotypic risk for type 2 diabetes.
|
| pubmed:affiliation |
Wells College, Aurora, New York, USA.
|
| pubmed:publicationType |
Journal Article
|